Yungjin Pharm. Co., Ltd. (003520.KS)
003520.KS Stock Price Chart
Explore Yungjin Pharm. Co., Ltd. interactive price chart. Choose custom timeframes to analyze 003520.KS price movements and trends.
003520.KS Company Profile
Discover essential business fundamentals and corporate details for Yungjin Pharm. Co., Ltd. (003520.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jan 2001
Employees
574.00
Website
https://www.yungjin.co.krCEO
Chae-Joon Lee
Description
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.
003520.KS Financial Timeline
Browse a chronological timeline of Yungjin Pharm. Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 15 Jan 2026
Upcoming earnings on 29 Oct 2025
Earnings released on 30 Jul 2025
EPS came in at ₩2.00 , while revenue for the quarter reached ₩62.52B .
Earnings released on 15 May 2025
EPS came in at ₩5.34 , while revenue for the quarter reached ₩64.07B .
Earnings released on 4 Mar 2025
EPS came in at -₩5.29 , while revenue for the quarter reached ₩62.85B .
Earnings released on 31 Oct 2024
EPS came in at -₩2.39 , while revenue for the quarter reached ₩62.04B .
Earnings released on 1 Aug 2024
EPS came in at -₩7.96 , while revenue for the quarter reached ₩62.20B .
Earnings released on 7 May 2024
EPS came in at ₩22.38 , while revenue for the quarter reached ₩64.95B .
Earnings released on 4 Mar 2024
EPS came in at -₩6.37 , while revenue for the quarter reached ₩64.31B .
Earnings released on 7 Nov 2023
EPS came in at -₩4.79 , while revenue for the quarter reached ₩59.37B .
Earnings released on 28 Jul 2023
EPS came in at -₩9.19 , while revenue for the quarter reached ₩57.03B .
Earnings released on 15 May 2023
EPS came in at -₩0.84 , while revenue for the quarter reached ₩54.19B .
Earnings released on 8 Feb 2023
EPS came in at -₩92.92 , while revenue for the quarter reached ₩59.57B .
Earnings released on 2 Nov 2022
EPS came in at -₩11.47 , while revenue for the quarter reached ₩54.33B .
Earnings released on 29 Jul 2022
EPS came in at -₩7.74 , while revenue for the quarter reached ₩52.15B .
Earnings released on 10 May 2022
EPS came in at -₩7.95 , while revenue for the quarter reached ₩52.33B .
Earnings released on 10 Feb 2022
EPS came in at -₩9.34 , while revenue for the quarter reached ₩53.92B .
Earnings released on 4 Nov 2021
EPS came in at -₩21.00 , while revenue for the quarter reached ₩49.46B .
Earnings released on 30 Jul 2021
EPS came in at -₩23.00 , while revenue for the quarter reached ₩49.04B .
Earnings released on 17 May 2021
EPS came in at -₩10.00 , while revenue for the quarter reached ₩43.65B .
Earnings released on 4 Feb 2021
EPS came in at -₩13.35 , while revenue for the quarter reached ₩50.72B .
Earnings released on 4 Nov 2020
EPS came in at -₩2.00 , while revenue for the quarter reached ₩49.97B .
003520.KS Stock Performance
Access detailed 003520.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.